P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy ; volume:13 ; number:1 ; day:21 ; month:5 ; year:2014 ; pages:1-7 ; date:12.2014
Molecular cancer ; 13, Heft 1 (21.5.2014), 1-7, 12.2014
- Urheber
-
Zhang, Ding-Guo
Zheng, Jun-Nian
Pei, Dong-Sheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-13-115
- URN
-
urn:nbn:de:101:1-2021082907513743355325
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Ding-Guo
- Zheng, Jun-Nian
- Pei, Dong-Sheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Metabolic regulation by p53
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
P53 regulated microRNAs in colorectal cancer
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anticancer activity of quantum size carbon dots: opportunities and challenges
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development
Erratum to: Metabolic regulation by p53
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
P53 regulated microRNAs in colorectal cancer
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anticancer activity of quantum size carbon dots: opportunities and challenges
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development
Erratum to: Metabolic regulation by p53
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
P53 regulated microRNAs in colorectal cancer
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anticancer activity of quantum size carbon dots: opportunities and challenges
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines